SeedToB Capital is a venture capital firm based in Suwanee, Georgia, founded in 2021. The firm specializes in healthcare technology, with a particular emphasis on artificial intelligence initiatives within the healthcare sector. Despite significant investments in AI applications, many do not reach their full potential, often remaining in pilot or early adopter stages. SeedToB Capital aims to address this challenge by guiding entrepreneurs through the complexities of the healthcare landscape, helping them find the most efficient path to secure Series B funding. The firm is led by seasoned entrepreneurs who previously founded Jvion, which became the largest clinical AI company in the nation before being sold in a significant cash transaction.
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making.
Shimmer
Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.
Feel Therapeutics
Venture Round in 2024
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Canid
Seed Round in 2023
Candid simplifies pediatricians’ work by redesigning how the vaccination process works. The company's scanning system eliminates the need for manual data entry and uploads vaccine information into state registries.
AngelEye Health
Series B in 2022
AngelEye Health offers a tele-engagement platform that facilitates the integration of parents into their child's care team during neonatal intensive care or pediatric stays. This HIPAA-compliant platform provides families with access to vital information about their child's treatment plan and progress through bedside cameras, patient communication tools, feeding management, and educational resources. By enhancing communication and involvement, AngelEye Health aims to improve family experiences, care delivery workflows, and patient outcomes, ultimately supporting a successful transition home. The platform is designed to be accessible from any connected device, allowing families to stay informed and engaged throughout their child's care journey.
Biotia
Series A in 2022
Biotia, Inc. is a health tech company based in New York, founded in 2016. It specializes in developing software and laboratory technology that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery. Biotia's solutions focus on microbial surveillance and tailored sequencing to reduce hospital-acquired infections. By enabling clinicians and researchers to identify and stop pathogens before patients fall ill, Biotia aims to improve patient treatment and health outcomes, thereby contributing to safer healthcare environments.
STRIVE
Series A in 2022
STRIVE operates a fitness platform designed to enhance muscle performance for athletes, military personnel, and industrial workers. The company employs advanced sensors integrated into compression clothing to collect detailed muscle and movement data through methods such as surface electromyography and accelerometers. This information enables users to monitor muscle activity, track fatigue, and prevent injuries, ultimately promoting improved performance. STRIVE's technology is utilized by elite athletes across various sports, including NCAA, NFL, and MLS, providing them with actionable insights to maintain peak performance.
curie ai
Seed Round in 2022
Curie AI is a tech-enabled respiratory care company providing virtual personalized disease management through proprietary AI that passively detects symptoms. This approach results in high adherence, reduction in adverse events, cost savings, and improving overall quality of life for people with chronic respiratory conditions
Zeit Medical
Seed Round in 2021
Zeit Medical provides therapy for neurological injuries by identifying signature patterns in EEG and enables physicians to diagnose and treat with precision. The company was founded in 20202019 by Urs Naber and Orestis Vardoulis.
GritWell
Seed Round in 2021
GritWell Ltd is a digital health platform established in 2018, based in San Francisco, California. The company focuses on addressing chronic health conditions by shifting the emphasis from symptom management to identifying and treating root causes. GritWell connects patients suffering from various chronic symptoms, such as insomnia, migraines, digestive issues, anxiety, and joint pain, with nutritionists, health coaches, and holistic practitioners. Its platform offers personalized care through clinically validated symptom assessments and facilitates secure video consultations, direct messaging, and an online portal for scheduling and managing patient records. By integrating natural treatments and providing tailored treatment plans, GritWell aims to enhance patient outcomes and support a holistic approach to health.
Feel Therapeutics
Seed Round in 2021
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
OncoLens
Series A in 2021
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.